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ABSTRACT: Bone tissue engineering (BTE) requires a sturdy biomaterial for scaffolds for restoration of large bone defects.
Ideally, the scaffold should have a mechanical strength comparable to the natural bone in the implanted site. We show that
adding cosolvent during the processing of our previously developed composite of hydroxyapatite−gelatin with a silane cross-
linker can significantly affect its mechanical strength. When processed with tetrahydrofuran (THF) as the cosolvent, the new
hydroxyapatite−gelatin composite can demonstrate almost twice the compressive strength (97 vs 195 MPa) and biaxial flexural
strength (222 vs 431 MPa) of the previously developed hydroxyapatite−gelatin composite (i.e., processed without THF),
respectively. We further confirm that this mechanical strength improvement is due to the improved morphology of both the
enTMOS network and the composite. Furthermore, the addition of cosolvents does not appear to negatively impact the cell
viability. Finally, the porous scaffold can be easily fabricated, and its compressive strength is around 11 MPa under dry conditions.
All these results indicate that this new hydroxyapatite−gelatin composite is a promising material for BTE application.
1. INTRODUCTION
Bone tissue engineering (BTE), an emerging field to deal with
bone defects, relies on using porous 3D scaffolds to provide
temporary support for bone regeneration.1 There are several
key considerations in designing a scaffold for BTE, including
biocompatibility, biodegradability, mechanical properties, scaf-
fold architecture, and fabrication technique.2 Among these,
developing a resorbable scaffold with sufficient mechanical
properties during the initial healing phase of bone regeneration
is a significant challenge; this is because commonly used
ceramics (e.g., tri-calcium phosphate) and polymers (e.g., poly-
L-lactic acid) typically demonstrate inadequate mechanical
strength.3
Currently, there are three major types of materials that are
used for BTE, namely, polymers, ceramics, and composites.4
Among these, composite materials have been shown to be a
promising option because they demonstrated tunable mechan-
ical strength, controllable degradation rate, and good
biocompatibility.5 In fact, bone itself is a composite material,
consisting of an organic component (collagen) and an
inorganic component (hydroxyapatite, HAp). Previously,
Chang et al. developed a hydroxyapatite−gelatin (HAp−Gel)
nanocomposite to mimic the structure of the nature bone.6
Similar to the interaction between various components in the
nature bone, HAp−Gel showed chemical bond formation
between calcium cations of HAp nanocrystals and carboxyl
anions of Gel macromolecules. Furthermore, HAp−Gel had a
self-organized structure along the c-axis of crystalline HAp
nanocrystals, which would account for the improved mechan-
ical strength of this composite.6 However, HAp−Gel was a
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particulate powder and hard to fabricate into scaffold. To make
it formable, the Ko group used an aminosilane [i.e., bis[3-
(trimethoxysilyl)propyl]ethylenediamine (enTMOS)] as the
chemical linker to facilitate the binding and solidification of
HAp−Gel and named such a composite as HAp−Gemosil (i.e.,
HAp−Gel modified with siloxane).7 Compared to previously
developed glutaraldehyde linker-treated HAp−Gel,8 this new
composite, HAp−Gemosil, demonstrated improved process-
ability and acceptable cell compatibility. Still, the compressive
strength of HAp−Gemosil was only ∼40% of the correspond-
ing value achieved by the cortical bone (80 vs 205 MPa9) under
the similar experimental condition, and the biaxial flexural
strength of HAp−Gemosil was merely ∼18% of that achieved
by the cortical bone (40 MPa vs 220 MPa10). To further
improve the mechanical strength of HAp−Gemosil, we have
attempted to incorporate biocompatible polymers to increase
the toughness of HAp−Gemosil. For example, we designed a
silane-functionalized poly(L-lactide-co-propargyl carbonate) co-
polymer to enhance the long-range interactions among
different components by incorporating this copolymer within
the HAp−Gemosil composite.11 However, this polymer-
enriched composite only improved the biaxial flexural strength
from 40 to 60 MPa, which is still much lower than that of the
natural bone.11 More recently, we introduced polydopamine
a mussel adhesive protein-inspired material that has excellent
coating and adhesion propertiesinto HAp−Gemosil, aiming
to improve the adhesion between the hydrophilic HAp−Gel
particles and the hydrophobic siloxane matrix. However, the
compressive strength improvement was still limited, only from
80 to 100 MPa, which was caused by the lack of long-range
interactions among different components in the composites.12
These results made us speculate that the main reason for the
poor mechanical strength of HAp−Gemosil might be the
intrinsically weak silane network in this composite. Given that
the silane matrix is the major component of the HAp−Gemosil
composite (∼46% by weight), engineering the silane network
to dramatically improve its mechanical strength would be an
alternativeperhaps an idealsolution. The silane network
formation is generally believed to go through a sol−gel process.
This process starts with hydrolysis of alkoxide silane precursors
to form silanol, followed by the condensation/polymerization
between the silanol groups to form siloxane (Si−O−Si)
linkages.13 The gel structure (e.g., morphology and porosity),
which decides the mechanical strength of the as-formed silane
network, can be significantly influenced by the processing
method and specific conditions, including pH, R ratio (R =
[H2O]/alkoxide precursor),
14 solvents,15 and drying process.13
As a result, to produce a gel with desirable properties, the
processing method and conditions need to be carefully
optimized. Processing conditions become even more important
when preparing composite materials that contain the silane
network. For instance, an inhomogeneous mixing of different
components in the composite can induce internal cracks during
drying,13,16 which can significantly decrease the final mechanical
strength of such composites.
Among aforementioned various factors that could influence
the gel structure, controlling the drying process of the sol to gel
formation has been shown to have a crucial impact on the
mechanical property of the final gel network.13 To improve the
drying while minimizing cracking, cosolvents17 have often been
employed. Theoretically, different cosolvents control different
kinetics of hydrolysis and condensation, resulting in different
morphologies of the silane network (Scheme 1) with different
physical properties.15 Thus, we hypothesized that control of
cosolvents in processing could further improve the mechanical
properties of HAp−Gemosil. Indeed, we find that by choosing
the appropriate cosolvent, as detailed below, the mechanical
strength of HAp−Gemosil can be greatly improved. Compared
with the original HAp−Gemosil, the new HAp−Gemosil
compositeprocessed with tetrahydrofuran (THF) as the
cosolventdemonstrated almost twice the mechanical strength
of the original one without THF (i.e., compressive strength: 97
vs 195 MPa and biaxial flexural strength: 222 vs 431 MPa).
Furthermore, we show that the improvement of the mechanical
strength is due to the improved morphology of the silane
network and the uniform distribution of HAp−Gel in the
enTMOS matrix.
2. EXPERIMENTAL DETAILS
2.1. Materials. HAp−Gel and Ca(OH)2 powders were
prepared by the method reported previously.6 Ca(OH)2 with
chlorhexidine (CHX) was prepared by doping 5−10% CHX
into Ca(OH)2 powder. enTMOS (95%) and 62% enTMOS in
methanol (MeOH) were purchased from Gelest, Inc. (Morris-
ville, PA, USA). Solvents, including methanol (MeOH),
ethanol (EtOH), acetonitrile (CH3CN), THF, tetrahydropyran
(THP), dimethyl sulfoxide (DMSO), dimethoxyethane
(DME), and 1,4-dioxane were purchased from Alfa Aesar and
used as received. Ammonium persulfate (APS) was purchased
from Sigma-Aldrich and used as received.
Scheme 1. enTMOS Network Formed in Different Solvent Systems
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2.2. Preparing the Composite. The method for making
the composites was adapted from the previous report.12 HAp−
Gel (300 mg) and 200 mg of Ca(OH)2 with CHX powder were
transferred into a mortar and ground into fine powder. Then,
the powdered mixture was spread on a glass sheet, which was
placed on a cold stage to maintain a depressed temperature
of20 °C. The premixed enTMOS solution, including 360 μL
of cosolvent, 200 μL of MeOH, and 500 μL of 95% enTMOS,
was then added into the powdered mixture quickly and mixed
continuously with a spatula for 30 s. Then, 80 μL of 7.5% APS
in MeOH/water (v/v = 3:7) was added to trigger the sol−gel
reaction. After mixing thoroughly, the mixture was poured into
a disk mold (size: diameter: 15.58 mm and thickness: 2.8 mm,
designed for 3-point bending test), which lay on a smooth glass
slide. Another smooth glass slide was carefully covered at the
top of the mold to remove extra material. This “sandwich”
structure (glass slides at the top and the bottom and material in
the disk mold in between) was clamped and sealed into a
plastic bag at room temperature for one week to let the
composite dry slowly. Finally, the sample was further dried in
an oven at 54 °C for 5 days before the flexural strength test.
The reason why the temperature was set at 54 °C is because
gelatin has been shown to degrade gradually around 100 °C,
and collagen has been shown to denature to gelatin between 60
and 80 °C. Thus, we chose 54 °C to remove the remaining
solvent as well as to avoid the degradation of gelatin or
collagen. For comparison, composites without cosolvents,
namely, all MeOH, were also prepared according to the same
procedure described above. Furthermore, the previously
reported HAp−Gemosil composite7 made from 62% enTMOS
was also repeated here as a reference. Additionally, cylinder-
shaped samples with a 1:2 ratio of diameter (3.8 mm) to length
(7.6 mm) were made according to our previous report with the
same composition as described above.12 To prepare a pure
enTMOS network without HAp−Gel and Ca(OH)2 CHX, APS
was directly added to the premixed enTMOS solution. After
gelation, the same drying process was applied as described
above.
2.3. Compressive and Biaxial Flexural Test. The testing
procedures were performed according to methods established
in our previous publication.11 Cylinder-shaped samples (3.8
mm diameter by 7.6 mm length) or disk-shaped samples (13
mm diameter by 2.5 mm thickness) were used for the
compression test and the 3-point bending test, respectively.
Mechanical testing was performed on an Instron machine
(model 4411, Instron Co., Norwood, MA, USA) with a cross-
head speed of 0.5 mm/min. The same calculation method11
was used to get compressive strength and biaxial flexural
strength. A minimum of three samples for each group were
used in all mechanical testing.
2.4. Fourier Transform Infrared. Bulk composites were
ground into fine powder. Then, the fine powder was spread
directly on the diamond crystal and analyzed by Fourier
transform infrared (FTIR) using the attenuated total reflection
mode.
2.5. 29Si Solid-State NMR. 29Si CPMAS NMR spectra were
acquired on a Bruker DMX 360 MHz WB NMR spectrometer
operating at 71.55 MHz for 29Si and at 360.13 MHz for 1H. A
Q8M8 (i.e., octakis(trimethylsiloxy)silsesquioxane) sample was
used to calibrate the proton pulse width and the silicon power
level for the contact pulse (10 ms). A relaxation delay of 5 s and
a sweep width of 27 kHz was used. Total number of scans
ranged from 4 to 16k. Spectra were processed with 50 Hz line
broadening and referenced to an external TMS sample.
2.6. Morphology Study. For scanning electron micros-
copy (SEM) analysis, a sample was carefully cut from the bulk
disk-shaped composite. Then, the sample cross section was
sputter-coated with gold in vacuum and imaged using Hitachi
S-4700 cold cathode field emission SEM (Hitachi High-
Technologies America, Inc.). Energy-dispersive X-ray spectros-
copy (EDS) analysis was performed to examine different phases
on sample’s cross section, which were analyzed by Inca
operator software. For transmission electron microscopy
(TEM) analysis, the bulk composite was ground into fine
powder and suspended into MeOH with sonication. Then, a
small drop of this solution was added to the TEM grid for
imaging using JEOL 2010F-FasTEM (JEOL USA, Inc.).
2.7. 3D Printing of the Composite. A 3D cylindrical
porous template (diameter: 5 mm, height: 10 mm, pore size:
400 μm, and porosity: 50%) was designed using SolidWorks
software (Dassault Systems SolidWorks Corp., Waltham, MA,
USA). This template (stl format) was then used to print a 3D
wax mold made of Solidcape Model (Solidscape Inc.,
Merrimack, NH, USA) with 0.16 mm2 trusses and 0.16 mm2
pore sizes (continuous space) using a Solidscape 3D printer
(Solidscape Inc., Merrimack, NH, USA). Next, the composite
mixture was prepared on the cold stage as described above and
injected to the 3D-printed mold before the materials were let to
solidify. After setting for 3−5 min, the wax mold and the
composite were immersed in acetone for 15 min to remove the
wax template and release the 3D porous composite-based
scaffold, which is shown in Figure 4a. The porous scaffold was
air-dried for one week, followed by drying at 52 °C for 4 days
prior to the compression test. The same method and data
analysis were used here to obtain the compressive strength. The
compressive strength of the porous scaffold was averaged from
at least three samples.
2.8. Bulk Material Biocompatibility Study via Real-
Time-Glo MT Cell Viability Assay. Bulk disk samples
(diameter: 6 mm and thickness: 1 mm) made from THF/
MeOH or MeOH were leached in H2O for 3 days, followed by
gas sterilization and balanced in the cell growth media
overnight. The disk samples were then seeded with rat
mesenchymal stem cells (rMSCs) in a Costar 48-well plate
and incubated at 37 °C overnight to allow cells to attach. Then,
the disk samples were transferred into a new 96-well opaque
plate to prevent interwell interference during measurement,
followed by the addition of NanoLuc luciferase and a cell-
permeant prosubstrate and incubated at 37 °C. At predeter-
mined time points (i.e., 0, 1, and 2 days), the illuminance of
each well with the substrate was measured by a Cytation 5 cell
imaging multi-mode reader. Each group with a minimum of
three samples was tested for each time. The cell viability result
was averaged from three separate measurements.
3. RESULTS AND DISCUSSION
3.1. Mechanical Strength of HAp−Gemosil with
Different Solvents: Observation. According to previous
findings, on the one hand, low viscosity solvents can promote
rapid hydrolysis which would likely promote fast condensation
reactions to occur (because of the increased concentration of
reactants for condensation), resulting in a condensed
network.15a On the other hand, nonpolar aprotic solvent is
preferred for a fast condensation reaction than polar protic and
aprotic solvents. This is because hydrogen bonding and/or
DOI: 10.1021/acsomega.7b01924
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electrostatic interactions between polar solvents and nucleo-
philic substitution reaction intermediates would slow the rate of
condensation.15b To form a dense network of silane and
thereby achieve higher mechanical strength of such a network,
one would need rapid hydrolysis and fast condensation
reactions. Thus, nonpolar aprotic solvents with low viscosity
would be ideal. To experimentally verify this hypothesis, we
chose a number of cosolvents in this study (Table 1). These
cosolvents have different viscosity values and can be categorized
into three different groups (i.e., polar protic, polar aprotic, and
nonpolar aprotic). Moreover, the addition of cosolvents will
ensure more homogenous mixing of the components in the
composite.
Our results in Table 1 clearly demonstrate that the cosolvent
indeed has a strong influence on the biaxial flexural strength of
the composite. First, as we expected, among the three types of
cosolvents we studied, aprotic oneswith the exception of
DMSOimprove the mechanical strength of the composite
more than protic ones. In some cases, we could even increase
the mechanical strength over 100% when compared with that of
the original HAp−Gemosil (prepared with MeOH only, entry 1
of Table 1). For instance, when using CH3CN and THF as the
cosolvents, the flexural strength of such composites increases
from 222 MPa to around 520 and 431 MPa, respectively (entry
3 and entry 5 in Table 1). This can be explained by the fact that
THF and CH3CN are aprotic in nature, which can promote fast
condensation reaction when compared with the protic ones
(such as MeOH and EtOH). Moreover, THF and CH3CN also
have relative lower viscosity values, which would likely promote
fast hydrolysis reaction of enTMOS. For these reasons, the
addition of THF or CH3CN would result in a dense silane
network, as shown in Scheme 1 with higher flexural strength.
This can be further proved by the impressive improvement of
compressive strength, which increases from 97 MPa when
processed with pure MeOH to 195 MPa when adding THF as
the cosolvent (Supporting Information Table S1, entries 2 and
4). However, if all MeOH was replaced by THF (i.e., THF
only) or CH3CN (i.e., CH3CN only), the sol−gel reaction
would be completed too fast (gelation time was reduced to 2
min from the original 5 min). The too fast cure rate would
result in the incomplete condensation reaction, evidenced by
the opaque color of pure enTMOS (Supporting Information
Figure S5c,e), leading to lower mechanical strength of such a
composite. For instance, the compressive strength and biaxial
flexural strength of the THF-only composite would decrease
from 195 to 72 MPa and 430 to 152 MPa, respectively (entry 4
and entry 5 in Table S1). Second, for cosolvents in the same
category, the boiling point of the cosolvent also plays a role in
the mechanical strength of the composite. For instance,
composites made from dioxane/MeOH and DME/MeOH
have different flexural strength, 291 vs 408 MPa (Table 1,
entries 7 and 8). It appears that a close match of the boiling
point of the cosolvent with that of MeOH (65 °C) would help
the drying process. In this specific case, the boiling point of
dioxane (101 °C) is too far from that of MeOH than the
boiling point of DME (85 °C). It is likely that having a
cosolvent with a boiling point similar to that of the primary
solvent can lead to a more uniform solvent evaporation, which
can help reduce the large cracks in the final composite and
result in higher mechanical strength. Finally, viscosity of the
cosolvent does not appear to have any correlation with the
flexural strength of the final composite. This can be seen from
cases of CH3CN/MeOH, THF/MeOH, and DME/MeOH. A
range of viscosity values (0.37, 0.52, and 1.1) were observed,
yet all cosolvents offered similarly high flexural strength of the
final composites (over 400 MPa).
3.2. Hypothesis. We hypothesize that the effect of the
cosolvent on the mechanical strength of the HAp−Gemosil
composite is mainly due to the combined effects from
hydrolysis and condensation of silanes that changed the
morphology of the composite, rather than from cosolvent-
induced chemical reactions/interactions between different
components within the composite. Specifically, adding
cosolvents into the processing solvent (i.e., MeOH) can have
two functions during the composite formation. First, mixing
different cosolvents with MeOH increases the total volume of
the solvent when compared with the original processing
method reported previously. The extra solvent would allow
the various components, including HAp−Gel, Ca(OH)2, and
enTMOS, to mix more homogenously. Second, the cosolvent
can have a subtle impact on the morphology of the enTMOS
network in the final composite (i.e., branched or condensed
network, shown in Scheme 1), likely caused by the different
rates of hydrolysis and condensation when a different cosolvent
is applied. As discussed earlier, the polarity and boiling point of
the cosolvent can have a direct impact on these fundamental
steps (i.e., hydrolysis and condensation) in the sol−gel process.
Macroscopically, composites processed with an appropriate
cosolvent would show less cracks/holes, which would benefit a
higher mechanical strength. Finally, because the solvent can be
completely removed during the drying process, the biocompat-
ibility of these composites can be maintained in addition to the
improved mechanical strength.
3.3. Fourier Transform Infrared Spectroscopy. To
experimentally verify the hypothesis, we first applied FTIR
spectroscopy to identify specific chemical bonds in the final gel
structure and to monitor the sol−gel reaction process.18 We
started with pure enTMOS gels formed from different
cosolvent/MeOH systems to probe whether the cosolvent
reacted with enTMOS. Three representative cosolvent/MeOH
systems from these three different types (Table 1) were
selected, THF/MeOH, CH3CN/MeOH, and MeOH only.
Table 1. Biaxial Flexural Strength of the Composite with Different Cosolvents
type of cosolvent entry cosolvent/MeOH (v/v = 9:5) viscosity of pure cosolvent boiling point of cosolvent (°C) biaxial flexural strength (MPa)
polar protic 1 MeOH 0.55 64.7 222.83 ± 54.80
2 EtOH/MeOH 1.07 78.37 102.32 ± 34.53
polar aprotic 3 CH3CN/MeOH 0.37 81.3 520.70 ± 15.48
4 DMSO/MeOH 1.99 189 138.01 ± 19.40
nonpolar aprotic 5 THF/MeOH 0.46 66 431.35 ± 58.72
6 THP/MeOH 0.52 88 471.40 ± 44.83
7 Dioxane/MeOH 1.18 101.1 291.05 ± 75.75
8 DME/MeOH 1.1 85 408.73 ± 51.38
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First, the FTIR of a pure enTMOS network prepared with
CH3CN/MeOH and THF/MeOH shows characteristic peaks
for enTMOS gels (e.g., Si−O−Si stretching at 1029 and 1118
cm−1), indicating the formation of an aminosilica matrix. As
expected, enTMOS gels made from different cosolvent/MeOH
systems demonstrated almost identical absorption spectra
(from 4000−400 cm−1) to that of the enTMOS gel made
from MeOH only (Figure 1a). This indicates that the cosolvent
did not react with the enTMOS during the sol−gel process.
Moreover, the almost identical absorbance of peaks corre-
sponding to the Si−O−Si bond for enTMOS processed with
different solvents indicates that the total amount of the Si−O−
Si bond is comparable across the samples. We also performed
29Si solid-state NMR to further investigate the variety of Si
bonds (e.g., Si−O−Si and Si−OH) that were involved in the
sol−gel process. As shown in the Supporting Information
Figure S2, for all silane networks with different processing
cosolvents, we observed two Si peaks. The signal at65 ppm is
corresponding to the formation of Si−O−Si, whereas the other
signal at58 ppm is attributed to the Si−OH structure from
the incomplete condensation.19 Again, the 29Si NMR spectra
are very similar across the samples, implying a similar amount
of Si species. Second, to examine whether the cosolvent would
react with other components in the HAp−Gemosil composite,
that is, HAp−Gel and Ca(OH)2 with CHX, we applied FTIR to
study the HAp−Gemosil composite. Again, these FTIR spectra
of composites made from different cosolvent/MeOH systems
are almost identical to each other (Figure 1b), indicating that
the cosolvent did not react with the remaining components
[i.e., HAp−Gel and Ca(OH)2 with CHX] in the HAp−
Gemosil system. Most importantly, we did not observe any
cosolvent/MeOH characteristic absorptions in all FTIR spectra,
indicating that the solvent was completely removed after
drying. This is ideal for BTE application because the residual
cosolvent (if any) could be toxic.
3.4. Morphology. Results from the FTIR study rule out the
possibility that the improvement of mechanical strength of
these cosolvent-treated composites was from cosolvent-induced
chemical interactions/reactions. Thus, it is very likely that the
optimized morphology of the HAp−Gemosil composite is the
main reason for the improved flexural strength. We next applied
SEM to investigate the morphology (i.e., phase distribution and
porosity) of the composite formed from different cosolvent/
MeOH systems and of a pure enTMOS network. We chose to
study the cross section of the composite made from two
representative cosolvent/MeOH systems, namely, CH3CN/
MeOH and THF/MeOH. We also investigated composites
made from MeOH and THF only as the reference. From the
cross-section images of these composites (Figure 2), one can
clearly observe that the composite formed from CH3CN/
MeOH or THF/MeOH has a much smoother surface (less
visual cracks), which agrees well with the greatly improved
flexural strength of the composites (Table 1). In contrast, the
composite made from MeOH only has large cracks (Figure 2a).
Furthermore, there are two distinct phases probed by EDS: one
is enriched with HAp−Gel, while the other is enriched with the
silsesquioxane phase (Supporting Information Figure S3).
Comparing the phase distribution in composites made from
MeOH only or THF only with that in composites made from
CH3CN/MeOH or THF/MeOH, the enTMOS phases and
HAp−Gel phases distribute more homogenously with the
addition of a cosolvent (CH3CN or THF). We attribute this
homogenous phase distribution to the increased total volume of
the solvent with the addition of the cosolvent, which would
help the homogenous mixing of different components.
More importantly, these cosolvents can control the drying
process of forming the HAp−Gemosil composite because the
mixed solvent (cosolvent + MeOH) would have a slower
evaporation rate than that of the pure MeOH. If this were the
case, a further deviation of the boiling point of the cosolvent
from that of the main solvent (i.e., MeOH) would have a more
appreciable effect on the drying process and the morphology of
the as-formed composite. Indeed, the composite made from
dioxane/MeOH (Supporting Information Figure S4c) shows
Figure 1. FTIR spectra of (a) enTMOS gels and (b) HAp−Gemosil composites prepared from different solvent systems.
Figure 2. SEM images of composites made from (a) MeOH only; (b)
CH3CN/MeOH; (c) THF/MeOH; and (d) THF only. Inset: the
physical appearance of the composite under that condition.
DOI: 10.1021/acsomega.7b01924
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larger cracks than the one made from THF/MeOH. This can
be ascribed to the fact that the boiling point of dioxane (101
°C) is too far from that of MeOH than that of THF (66 °C).
While our results show that mixing cosolvents into the main
solvent can be beneficial to improving the morphology and
mechanical strength of our composites, having pure cosolvents
alone (i.e., cosolvent as the sole solvent) cannot offer the same
improvement. This can be seen by comparing the composite
made from cosolvent/MeOH with that made from THF only.
The composite made with THF only shows less homogeneity
and weaker mechanical strength (Figure 2d and entry 5 in
Table S1). We speculate that rapid gelation would occur when
pure THF was used, which would lead to the inhomogeneous
mixing of different components in the composite.
Finally, we applied TEM to investigate more details about
each component in the composite. In principle, if the cosolvent
did not react with the HAp−Gel crystal, we should be able to
observe intact HAp−Gel crystals. Indeed, TEM images of
composites show that the HAp−Gel nanocrystals remain intact
after the processing with cosolvents (Supporting Information
Figure S6). This further proves that the improvement of
mechanical strength by these cosolvents could be solely related
to the optimized enTMOS matrix structure and the more
homogenous mixing of different components in the composite.
3.5. Biocompatibility Study. Good biocompatibility of the
composite is a prerequisite for BTE. A previous study has
demonstrated that HAp−Gemosil has good biocompatibility.7
In the current study, we add a cosolvent and CHX as additional
components during the processing, and there is a possibility
that the residual cosolvent and CHX could lead to cell toxicity.
To investigate this possible pitfall, the following experiments
were carried out. We chose THF/MeOH as the representative
cosolvent/MeOH system and varied the amount of the
cosolvent and CHX as independent variables. Experimentally,
four different types of composites made from (a) MeOH and
Ca(OH)2, (b) MeOH and Ca(OH)2 CHX, (c) THF/MeOH
and Ca(OH)2, and (d) THF/MeOH and Ca(OH)2 CHX were
incubated with cells. The viability of the potential transplanted
cells in BTE application, rMSCs, was monitored by RealTime-
Glo MT cell viability assay. We used this method to distinguish
the direct toxicity monitored by the cells attached to the
composites and the leaching toxicity measured by the cells in
the well surrounding the bulk materials. However, a quick
screening showed poor cell attachment on the bulk composite
made from Ca(OH)2 with CHX and its surrounding area in the
cell culture well, which indicated acutely direct and leaching
cytotoxicity resulting from CHX. We thus focused on
comparing the cell toxicity of group (a) and group (c) to
understand the impact of THF on cell viability. As shown in
Figure 3, the luminescent reading gradually increased from day
0 to day 1, suggesting that the addition of THF during the
composite processing did not decrease the cell viability
compared with the nontoxic composite processed with
MeOH only. The decreased luminescence on day 2 may result
from either the exhaustion of reagents or the confluency of cells
on the composite. Importantly, we further discovered that even
when we replaced Ca(OH)2 CHX with just Ca(OH)2, the
compressive strength of composites (with or without CHX)
was comparable (Supporting Information Table S2). Therefore,
we recommend to replace Ca(OH)2 CHX with Ca(OH)2 for
future use of the composites where good biocompatibility is
required.
3.6. 3D-Printed Scaffold Formation and Mechanical
Testing. In addition to biocompatibility, other important
considerations for scaffolds intended for BTE include the
feasibility of forming porous structures yet still maintaining
good mechanical strength. To this end, we fabricated a 3D
porous structure with the HAp−Gemosil (THF/MeOH)
composite via computer-aided design. A good control on the
porous architecture can be achieved (Figure 4a). Moreover,
porous scaffold processed with THF/MeOH has a compressive
strength ∼11.33 ± 1.25 MPa, increased by ∼ 60% compared to
the compressive strength of the scaffold processed with MeOH
(6.94 ± 1.01 MPa) (Figure 4b). This increment further proves
the effect of cosolvents in improving mechanical strength of the
HAp−Gemosil composite. Furthermore, the achieved com-
pressive strength of the scaffold processed with cosolvents is
comparable to that (1−13 MPa) of the cancellous bone.20 All
these indicate a great potential of such a scaffold for BTE.
Further, the in vivo test is in progress to access the feasibility of
such scaffolds for biomedical applications.
4. CONCLUSIONS
In conclusion, we successfully improved the mechanical
strength of our previously developed HAp−Gemosil composite
significantly with the aid of selected cosolvents (e.g., THF,
CH3CN, THP, etc.). We further demonstrated that the
improvement of mechanical strength was not due to chemical
interactions/reactions between the different components in
HAp−Gemosil and cosolvents. Instead, adding cosolvents
helped the enTMOS network formation and the composite
processing. As a result, the likely uniformly cross-linked
Figure 3. Cell viability test by RealTime-Glo MT cell viability assay
(two way ANOVA analysis, P = 0.0012).
Figure 4. (a) Picture of the porous scaffold (pore size: 400 μm,
porosity: 50%) and (b) mechanical strength of the porous scaffold
processed with different cosolvents (student t-test, P = 0.0001).
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enTMOS matrix and the more homogenous composite would
result in higher mechanical strength. Moreover, we showed that
the cosolvent/MeOH could be completely removed from the
composite during the drying process, thus having minimum
impact on the biocompatibility of this new HAp−Gemosil
composite. Finally, we demonstrated that the porous scaffold
processed with cosolvents can be easily made yet can maintain
good compressive strength. All these results point to that this
newly modified HAp−Gemosil composite is a very promising
candidate for BTE. Currently, we focus on evaluating the effect
of this new scaffold for bone regeneration in vivo.
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